Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Edwards Lifesciences Corp    EW

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Edwards Lifesciences Corp : Edwards Lifesciences' Chairman and CEO to Exercise Stock Options Under 10b5-1 Stock Trading Plan

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/01/2013 | 04:37pm CET

IRVINE, CA, March 01, 2013 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that its chairman and chief executive officer, Michael A. Mussallem, has adopted a pre-arranged stock trading plan under Rule 10b5-1 of the Securities and Exchange Act of 1934. In May 2013, the plan will begin exercising stock options, the vast majority of which are scheduled to expire in 2014.

The plan anticipates the exercise and sale of 29,500 shares per month at market prices between May 2013 and April 2014. Rule 10b5-1 allows corporate executives to adopt stock trading plans to buy or sell shares of company stock when they are not in possession of material, non-public information. Mussallem plans to enter into similar types of trading plans each year as stock options near their expiration dates in order to spread sales evenly over an extended period of time.

Under the company's stock ownership guidelines, Mussallem is required to own shares of company stock with an aggregate market value equal to six times his base salary. At the conclusion of the plans, Mussallem will still hold shares well in excess of the number required to meet these guidelines. Transactions under these plans will be disclosed publicly through Form 144 and Form 4 filings with the U.S. Securities and Exchange Commission. The Form 4 filings will also be posted on Edwards' investor relations Web site at ir.edwards.com.

About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at edwards.com.

Edwards, Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation.

# # #


distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EDWARDS LIFESCIENCES CORP
01/23 EDWARDS LIFESCIENCES CORP : Completion of Acquisition or Disposition of Assets, ..
01/23 EDWARDS LIFESCIENCES : Completes Acquisition Of Valtech Cardio
01/19 EDWARDS LIFESCIENCES : Trademark Application for "ASCENDRA" Filed by Edwards Lif..
01/19 EDWARDS LIFESCIENCES : Trademark Application for "PACEPORT" Filed by Edwards Lif..
01/19 EDWARDS LIFESCIENCES : An Application for the Trademark "PERIMOUNT THEON" Has Be..
01/19 EDWARDS LIFESCIENCES : An Application for the Trademark "NOVAFLEX" Has Been File..
01/19 EDWARDS LIFESCIENCES' : Trademark Application for "FLOTRAC" Filed
01/18 EDWARDS LIFESCIENCES : To Present At The 35th Annual J.P. Morgan Healthcare Conf..
01/17 EDWARDS LIFESCIENCES : To Host Earnings Conference Call On February 1, 2017
01/03 EDWARDS LIFESCIENCES : To Present At The 35th Annual J.P. Morgan Healthcare Conf..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
07:56aDJPHILIPS : Swings to Profit as Sales Rise
01/23 PHILIPS LIGHTING : sees brighter 2017 as fourth-quarter profit disappoints
01/19 Davos CEOs 'go local' on supply chain in Trump era
01/08DJCorrection to Parkinson's Therapy Story
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
01/23 Edwards completes Valtech buy
01/11 Dow Rally Is Running Out Of Steam - Cramer's Mad Money (1/10/17)
01/10 Edwards Lifesciences (EW) Investor Presentation - Slideshow
01/04 Political Ructions, Poor Deal-Making And Scandal - A Bad Year For Big-Cap Med..
01/04 Medtech News Over The Christmas Period
Advertisement
Financials ($)
Sales 2016 2 955 M
EBIT 2016 817 M
Net income 2016 591 M
Finance 2016 709 M
Yield 2016 -
P/E ratio 2016 35,27
P/E ratio 2017 28,14
EV / Sales 2016 6,63x
EV / Sales 2017 5,95x
Capitalization 20 312 M
More Financials
Chart EDWARDS LIFESCIENCES CORP
Duration : Period :
Edwards Lifesciences Corp Technical Analysis Chart | EW | US28176E1082 | 4-Traders
Full-screen chart
Technical analysis trends EDWARDS LIFESCIEN...
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 116 $
Spread / Average Target 22%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Stanton J. Rowe Chief Scientific Officer & VP-Advanced Technology
John T. Cardis Independent Director
William J. Link Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
EDWARDS LIFESCIENCES C..1.39%20 312
THERMO FISHER SCIENTIF..1.20%56 406
DANAHER CORPORATION2.77%55 336
BOSTON SCIENTIFIC CORP..9.48%32 245
PHILIPS-3.72%27 831
INTUITIVE SURGICAL, IN..3.29%25 380
More Results